WebMD

Heart Disease and Hypertrophic Cardiomyopathy

What Are the Symptoms of Hypertrophic Cardiomyopathy? Many people with HCM have no symptoms or only minor symptoms and live a normal life. Other people develop symptoms, which progress and worsen as ...
Everyday Health on MSN

Exercising With Hypertrophic Cardiomyopathy (HCM): What You Need to Know

Learn about hypertrophic cardiomyopathy (HCM) and exercise, including safety tips, guidelines, and how best to stay active with this heart condition.
Medscape

Treatment for Obstructive Hypertrophic Cardiomyopathy Approved

In a move greatly welcomed by heart charities, the National Institute for Health and Care Excellence (NICE) has approved mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy ...

Imbria Pharmaceuticals Partners with Hypertrophic Cardiomyopathy Association to Support FORTITUDE-HCM Trial Evaluating Ninerafaxstat for Non-Obstructive Hypertrophic Cardiomyopathy

Partnership further supports trial recruitment; FORTITUDE-HCM to be highlighted at upcoming HCMA Annual Patient MeetingEnrollment underway for ...
Healio

FDA approves mavacamten, first treatment for obstructive hypertrophic cardiomyopathy

Please provide your email address to receive an email when new articles are posted on . The FDA approved mavacamten for the treatment of symptomatic, obstructive hypertrophic cardiomyopathy, the first ...
Healio

AHA/ACC: Shared decision-making key in diagnosis, treatment of hypertrophic cardiomyopathy

Please provide your email address to receive an email when new articles are posted on . “Shared decision-making, a dialogue between patients and their care team that includes full disclosure of all ...
Medscape

Mavacamten Controlled Hypertrophic Cardiomyopathy for >1 Year

WASHINGTON – Treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy who remained on treatment with the investigational agent mavacamten for a median of 62 weeks continued to ...
Monthly Prescribing Reference

Aficamten Looks Promising for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Treatment with aficamten improved exercise capacity in patients with symptomatic obstructive hypertrophic cardiomyopathy when compared with placebo. Treatment with aficamten improved exercise capacity ...
UUHC Health Feed

Septal Myectomy for Hypertrophic Cardiomyopathy

The Hypertrophic Cardiomyopathy (HCM) Program at University of Utah Health is one of the nation’s few programs for comprehensive HCM evaluation and management. Our multidisciplinary team works ...
Everyday Health on MSN

Complications of Hypertrophic Cardiomyopathy (HCM)

Learn about the complications of hypertrophic cardiomyopathy (HCM), including arrhythmias, heart block, and heart failure, as ...
European Medical Journal

Aficamten versus Metoprolol in Obstructive Hypertrophic Cardiomyopathy: Recent Analyses of the MAPLE-HCM Trial

Beta-blockers have been the cornerstone of treatment for obstructive hypertrophic cardiomyopathy for almost 6 years. Recent ...

Bristol Myers Squibb launches Kopozgo in India for treatment of symptomatic Obstructive Hypertrophic Cardiomyopathy

Bristol Myers Squibb (BMS) today announced the launch of Kopozgo® (Mavacamten) in India -- the first and only oral, selective cardiac myosin inhibitor approved in the country for the treatment of ...